Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists

ConclusionWe did not find evidence for a better or worse response to GnRH agonists in men with PCa who were also on drugs for hypertension, dyslipidaemia, or hyperglycaemia.This article is protected by copyright. All rights reserved.

Source: BJU International - September 20, 2017 Category: Urology & Nephrology Authors: Cecilia Bosco, Chloe Wong, Hans Garmo, Danielle Crawley, Lars Holmberg,, Niklas Hammar, Jan Adolfsson, P är Stattin, Mieke Van Hemelrijck Tags: Original Article Source Type: research